Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)

CNY 21.92

(2.77%)

Operating Expenses Summary of Vcanbio Cell & Gene Engineering Corp., Ltd

  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest annual operating expenses in 2023 was 953.58 Million CNY , up 4.12% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest quarterly operating expenses in 2024 Q3 was 222.81 Million CNY , up 1.88% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a annual operating expenses of 882.01 Million CNY in annual operating expenses 2022, up 0.57% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a annual operating expenses of 876.98 Million CNY in annual operating expenses 2021, up 16.17% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a quarterly operating expenses of 222.81 Million CNY for 2024 Q3, up 1.88% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a quarterly operating expenses of 221.38 Million CNY for 2024 Q2, up 2.15% from previous quarter.

Annual Operating Expenses Chart of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1993)

Historical Annual Operating Expenses of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1993)

Year Operating Expenses Operating Expenses Growth
2023 953.58 Million CNY 4.12%
2022 882.01 Million CNY 0.57%
2021 876.98 Million CNY 16.17%
2020 754.92 Million CNY 2.27%
2019 738.19 Million CNY -3.83%
2018 767.61 Million CNY 44.25%
2017 532.14 Million CNY 25.38%
2016 424.41 Million CNY 19.74%
2015 354.45 Million CNY 18.77%
2014 298.42 Million CNY 19.85%
2013 248.99 Million CNY 20.01%
2012 207.47 Million CNY 35.66%
2011 152.94 Million CNY 0.79%
2010 151.74 Million CNY -10.96%
2009 170.42 Million CNY 22.59%
2008 139.02 Million CNY 9.6%
2007 126.84 Million CNY 2.82%
2006 123.36 Million CNY -13.11%
2005 141.97 Million CNY 6.72%
2004 133.03 Million CNY 163.63%
2003 50.46 Million CNY -40.25%
2002 84.45 Million CNY 124.04%
2001 37.69 Million CNY 76.59%
2000 21.34 Million CNY 3.83%
1999 20.55 Million CNY -27.17%
1998 28.22 Million CNY -19.47%
1997 35.05 Million CNY 46.01%
1996 24 Million CNY 63.8%
1995 14.65 Million CNY 10676.91%
1994 136 Thousand CNY -98.57%
1993 9.52 Million CNY 0.0%

Peer Operating Expenses Comparison of Vcanbio Cell & Gene Engineering Corp., Ltd

Name Operating Expenses Operating Expenses Difference
Beijing Tiantan Biological Products Co., Ltd. 824.72 Million CNY -15.624%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 614.32 Million CNY -55.224%
Jinyu Bio-technology Co., Ltd. 630.76 Million CNY -51.178%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 1.38 Billion CNY 30.982%
Zhejiang Ausun Pharmaceutical Co., Ltd. 158.79 Million CNY -500.529%
DaShenLin Pharmaceutical Group Co., Ltd. 7.17 Billion CNY 86.711%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 3.13 Billion CNY 69.6%
GuiZhou SanLi Pharmaceutical Co.,Ltd 861.16 Million CNY -10.732%
Pulike Biological Engineering, Inc. 571.28 Million CNY -66.92%
Beijing Konruns Pharmaceutical Co.,Ltd. 675.67 Million CNY -41.129%
Shanghai Hile Bio-Technology Co., Ltd. 68.54 Million CNY -1291.124%
Qingdao Vland Biotech INC. 431.31 Million CNY -121.088%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 422.38 Million CNY -125.76%
Aurisco Pharmaceutical Co.,Ltd. 375.24 Million CNY -154.122%
Zhejiang East Asia Pharmaceutical Co., Ltd. 211.78 Million CNY -350.27%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 860.45 Million CNY -10.823%
Mabwell (Shanghai) Bioscience Co., Ltd. 1.17 Billion CNY 19.122%
Beijing Hotgen Biotech Co., Ltd. 314.19 Million CNY -203.498%
Assure Tech (Hangzhou) Co., Ltd. 36.27 Million CNY -2528.558%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 399.61 Million CNY -138.625%
Cabio Biotech (Wuhan) Co., Ltd. 106.55 Million CNY -794.913%
Shanghai Shen Lian Biomedical Corporation 177.43 Million CNY -437.429%
Nanjing Vazyme Biotech Co., Ltd. 1.01 Billion CNY 5.922%
Shandong Kexing Bioproducts Co,.Ltd 1.12 Billion CNY 14.953%
Shanghai Junshi Biosciences Co., Ltd. 3.21 Billion CNY 70.318%
Shanghai Model Organisms Center, Inc. 182.57 Million CNY -422.29%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 710.45 Million CNY -34.221%
Xiamen Amoytop Biotech Co., Ltd. 1.27 Billion CNY 25.294%
Novogene Co., Ltd. 640.67 Million CNY -48.84%
Shanghai ZJ Bio-Tech Co., Ltd. 141.69 Million CNY -572.968%
Chengdu Olymvax Biopharmaceuticals Inc. 461.02 Million CNY -106.841%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 545.28 Million CNY -74.877%
Shanghai Haohai Biological Technology Co., Ltd. 1.45 Billion CNY 34.461%
Jiangsu Bioperfectus Technologies Co., Ltd. 622.73 Million CNY -53.127%
Jiangsu Aidea Pharmaceutical Co., Ltd. 258.4 Million CNY -269.026%
Chengdu Easton Biopharmaceuticals Co., Ltd. 652.1 Million CNY -46.23%
Sinocelltech Group Limited 1.77 Billion CNY 46.237%
Wuhan Keqian Biology Co.,Ltd 307.99 Million CNY -209.608%
Shanghai Allist Pharmaceuticals Co., Ltd. 1.28 Billion CNY 25.655%
Anhui Huaheng Biotechnology Co., Ltd. 274.4 Million CNY -247.504%
Youcare Pharmaceutical Group Co., Ltd. 2.39 Billion CNY 60.236%
Jiangsu gdk Biotechnology Co., Ltd. 186.4 Million CNY -411.559%
Beijing Kawin Technology Share-Holding Co., Ltd. 1 Billion CNY 5.481%
Hangzhou Biotest Biotech Co.,Ltd. 105.69 Million CNY -802.189%